Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19
pubmed:dateCreated
2009-11-6
pubmed:abstractText
Somatic mutations of Kit have been found in leukemias and gastrointestinal stromal tumors. The proto-oncogene c-Cbl negatively regulates Kit and Flt3 by its E3 ligase activity and acts as a scaffold. We recently identified the first c-Cbl mutation in human disease in an acute myeloid leukemia patient, called Cbl-R420Q. Here we analyzed the role of Cbl mutants on Kit-mediated transformation. Coexpression of Cbl-R420Q or Cbl-70Z with Kit induced cytokine-independent proliferation, survival, and clonogenic growth. Primary murine bone marrow retrovirally transduced with c-Cbl mutants and transplanted into mice led to a generalized mastocytosis, a myeloproliferative disease, and myeloid leukemia. Overexpression of these Cbl mutants inhibited stem cell factor (SCF)-induced ubiquitination and internalization of Kit. Both Cbl mutants enhanced the basal activation of Akt and prolonged the ligand-dependent activation. Importantly, transformation was observed also with kinase-dead forms of Kit and Flt3 in the presence of Cbl-70Z, but not in the absence of Kit or Flt3, suggesting a mechanism dependent on receptor tyrosine kinases, but independent of their kinase activity. Instead, transformation depends on the Src family kinase Fyn, as c-Cbl coimmunoprecipitated with Fyn and inhibition abolished transformation. These findings may explain primary resistance to tyrosine kinase inhibitors targeted at receptor tyrosine kinases.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
1528-0020
pubmed:author
pubmed:issnType
Electronic
pubmed:day
5
pubmed:volume
114
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4197-208
pubmed:meshHeading
pubmed-meshheading:19734451-Animals, pubmed-meshheading:19734451-Bone Marrow Transplantation, pubmed-meshheading:19734451-COS Cells, pubmed-meshheading:19734451-Cell Transformation, Neoplastic, pubmed-meshheading:19734451-Cercopithecus aethiops, pubmed-meshheading:19734451-Disease Models, Animal, pubmed-meshheading:19734451-Female, pubmed-meshheading:19734451-Humans, pubmed-meshheading:19734451-Ligands, pubmed-meshheading:19734451-Mastocytosis, pubmed-meshheading:19734451-Mice, pubmed-meshheading:19734451-Mice, Inbred BALB C, pubmed-meshheading:19734451-Mutagenesis, Site-Directed, pubmed-meshheading:19734451-Mutation, pubmed-meshheading:19734451-Myeloproliferative Disorders, pubmed-meshheading:19734451-Proto-Oncogene Proteins c-cbl, pubmed-meshheading:19734451-Proto-Oncogene Proteins c-kit, pubmed-meshheading:19734451-Signal Transduction, pubmed-meshheading:19734451-Ubiquitination
pubmed:year
2009
pubmed:articleTitle
E3 ligase-defective Cbl mutants lead to a generalized mastocytosis and myeloproliferative disease.
pubmed:affiliation
Department of Medicine, Hematology and Oncology and the Interdisciplinary Center for Clinical Research, University Hospital Muenster, Muenster, Germany.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't